AMTHEH CODA: Open Payments
NPI 1952024630 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 12 payments from 9 companies in 2025. Trend: 2023 $423 · 2024 $600 · 2025 $565
Food & beverage: $565
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 1 | $146 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $104 |
| Amgen Inc. | 1 | $93 |
| Lilly USA, LLC | 3 | $72 |
| Novo Nordisk Inc | 2 | $46 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| Exact Sciences Corporation | 1 | $21 |
Products named: AMVUTTRA, Kerendia, REPATHA, MOUNJARO, BEXSERO, GARDASIL 9, BREZTRI, Rybelsus.
Industry payments across CA — which companies pay providers there.
